HCLS Review Middle East & North Africa Data by Country is an extensive compilation of the latest country-specific data on economies, healthcare, pharmaceutical industries, and R&D in some of the region’s most dynamic markets. This new 51-page report contains data from Algeria, Egypt, Iran, Morocco, Saudi Arabia, Turkey, and the United Arab Emirates and is an invaluable resource for anyone looking for up-to-date statistics and trends on these key geographies.
The MENA region is rapidly developing and extremely diverse, spanning both countries at the cutting-edge of innovation and technology as well as emerging economies. According to TradeArabia, the territory’s pharmaceutical market stands to grow to USD 60 billion by 2025 driven by significant growth in the UAE as well as in North African giants Egypt and Algeria.
Factors accounting for this leap include sizeable population growth, increased life expectancy, greater prevalence of lifestyle-related diseases such as diabetes, and a greater prioritization of healthcare services among governments in the region.